Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Top Pastry: What's Your Sweet Treat of Decision?- Step by step instructions to Guarantee the Strength and Life span of Your Pre-assembled Home
- A Pompeii site reveals the recipe for Roman concrete. It contradicts a famous architect’s writings
- Find the Effect of Web-based Entertainment on Psychological wellness: Exploring the Advanced Scene Securely
- Find Wonderful Stream Voyage Objections On the planet
- NASA's Perseverance Mars rover could break the record for miles driven on another planet
- Canada's Serene Lakeside Mountain Village Is A Breathtaking Oasis For Outdoor Adventure
- Find Your Internal Culinary expert: Cooking Strategies and Recipes
- Figure out How to Get the Best Open Record Rewards
